Walleye Capital LLC Purchases New Holdings in Viemed Healthcare $VMD

Walleye Capital LLC purchased a new stake in shares of Viemed Healthcare (CVE:VMD – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 183,909 shares of the company’s stock, valued at approximately $2,097,000.

Viemed Healthcare Stock Down 2.0%

CVE:VMD opened at C$4.95 on Friday. Viemed Healthcare has a twelve month low of C$1.65 and a twelve month high of C$5.34. The stock’s 50 day moving average price is C$4.95 and its two-hundred day moving average price is C$4.95.

Get Viemed Healthcare alerts:

About Viemed Healthcare

(Free Report)

Viemed Healthcare, Inc, through its subsidiaries, provides in-home health care solutions in the United States. It offers respiratory services and related equipment, including non-invasive ventilators, positive airway pressure machines, and oxygen units, as well as services of respiratory therapists. The company also provides in-home sleep apnea testing to determine the existence of sleep apnea at home. In addition, it leases equipment, including non-invasive ventilators, bi-level devices and CPaP, percussion vests, and various supplies and peripheral equipment, as well as sells medical equipment and patient monitoring services.

Further Reading

• Five stocks we like better than Viemed Healthcare
• Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
• Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
• NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
• Sandisk’s Margins Look Like Software. Can They Last?

Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare (CVE:VMD – Free Report).

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.